GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $531,000 | +101.9% | 15,177 | +149.9% | 0.05% | +85.7% |
| Q4 2020 | $263,000 | -24.4% | 6,074 | -3.8% | 0.03% | -53.3% |
| Q3 2020 | $348,000 | -42.7% | 6,316 | -34.3% | 0.06% | -14.3% |
| Q2 2020 | $607,000 | +37.6% | 9,612 | +73.3% | 0.07% | +62.8% |
| Q4 2019 | $441,000 | -8.7% | 5,548 | -44.3% | 0.04% | +13.2% |
| Q3 2019 | $483,000 | -46.6% | 9,959 | -42.1% | 0.04% | -28.3% |
| Q2 2019 | $905,000 | +266.4% | 17,206 | +268.1% | 0.05% | +278.6% |
| Q1 2019 | $247,000 | -73.2% | 4,674 | -80.7% | 0.01% | -75.0% |
| Q3 2018 | $921,000 | +254.2% | 24,241 | +321.8% | 0.06% | +366.7% |
| Q2 2018 | $260,000 | +4.8% | 5,747 | +12.0% | 0.01% | -7.7% |
| Q1 2018 | $248,000 | -30.3% | 5,132 | -55.2% | 0.01% | -27.8% |
| Q3 2017 | $356,000 | – | 11,450 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 327,905 | $17,248,000 | 9.44% |
| Asymmetry Capital Management, L.P. | 314,217 | $16,528,000 | 8.95% |
| Perceptive Advisors | 5,775,726 | $303,803,000 | 6.97% |
| NEXTHERA CAPITAL LP | 142,305 | $7,485,000 | 6.23% |
| Grace Capital | 244,914 | $12,882,000 | 6.14% |
| Broadfin Capital, LLC | 316,619 | $16,654,000 | 3.62% |
| Ghost Tree Capital, LLC | 300,000 | $15,780,000 | 3.27% |
| ArchPoint Investors | 156,635 | $8,239,000 | 2.61% |
| STANSBERRY ASSET MANAGEMENT, LLC | 114,562 | $6,026,000 | 2.37% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 13,928 | $733,000 | 2.07% |